| Literature DB >> 34247428 |
Xiuli Xu1,2, Guanjun Deng1,3, Zhihong Sun1,3,4, Yuan Luo1,3, Junkai Liu3, Xinghua Yu1,3, Yang Zhao5, Ping Gong1, Guozhen Liu6,7, Pengfei Zhang1,3,8, Fan Pan1,9, Lintao Cai1,10, Ben Zhong Tang3,8,11.
Abstract
Photodynamic therapy (PDT) is a promising alternative approach for effective cancer treatment that is associated with an antitumor immune response. However, immunosuppression of the tumor microenvironment limits the immune response induced by PDT. Stimulation and proliferation of T cells is a critical step for generating immune responses and depends on the efficient presentation of tumor antigens and co-stimulatory molecules by antigen-presenting cells (APCs). Here, biomimetic aggregation-induced emission (AIE) photosensitizers with antigen-presenting and hitchhiking abilities (DC@AIEdots) are developed by coating dendritic cell (DC) membranes on the nanoaggregates of the AIEgens. Notably, the inner AIE molecules can selectively accumulate in lipid droplets of tumor cells, and the outer cell membrane can facilitate the hitchhiking of DC@AIEdots onto the endogenous T cells and enhance the tumor delivery efficiency by about 1.6 times. Furthermore, DC@AIEdots can stimulate the in vivo proliferation and activation of T cells and trigger the immune system. The potential applications of therapeutic agents targeting lipid droplets for immunotherapy are indicated and a new hitchhiking approach for drug delivery is provided. Lastly, the study presents a photoactive and artificial antigen-presenting platform for effective T cell stimulation and cancer photodynamic immunotherapy.Entities:
Keywords: aggregation-induced emission; antigen presenting functions; lipid droplets; photodynamic immunotherapy; photosensitizers
Mesh:
Substances:
Year: 2021 PMID: 34247428 DOI: 10.1002/adma.202102322
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849